Europe

Magazine articles on conducting business in European countries.

Old Articles: <Older 3101-3110 Newer>

Chemistry World February 27, 2013 Andrew Turley	Talk of a $6.6bn deal for Elan Irish drug maker Elan has been surprised by a potential $6.6 billion offer being mooted by investment firm Royalty Pharma.
Chemistry World February 14, 2013 Andrew Turley	BMS sells OTC drugs for $482m UK consumer goods giant Reckitt Benckiser has struck a $482 million deal to buy from Bristol-Myers Squibb rights to a range of over-the-counter drugs in parts of Latin America, including Brazil and Mexico.
Chemistry World December 14, 2012 Nuala Moran	Single EU patent agreed for 2014 After 40 years of debate and diplomacy, a historic agreement to establish a single, harmonized European patent system has been achieved.
On Wall Street December 1, 2012 Milton Ezrati	Europe's Hidden Growth Agenda Amid Austerity Longer-term fundamental reform will redress underlying differences within Europe.
Pharmaceutical Executive November 1, 2012	Country Report: Czech Republic The '90s was an enthusiastic time. With the fall of communism in 1989 and the emergence of the free economy, the international pharmaceutical industry arrived in the Czech Republic to find a highly receptive market.
Commercial Investment Real Estate Nov/Dec 2012	International Beat More than half of the world's $141.7 billion in cross-border acquisitions in the past year took place in Europe, according to Real Capital Analytics.
Chemistry World October 31, 2012 Andrew Turley	More jobs go: Lonza cuts 500 Swiss speciality chemical company Lonza is to cut 500 jobs over the next two years to save costs, including 400 cut in a bid to 'secure the future' of the site at Visp in Switzerland.
Chemistry World October 25, 2012 Eugene Gerden	Problems for Russian chemicals? The Russian chemical industry could be on the verge of a serious crisis caused by state plans to abolish subsidies to domestic producers.
Chemistry World October 11, 2012 Patrick Walter	Slump in confidence hits EU chemical industry EU chemical production has stalled again after staging a brief recovery after the global economic crisis hit. Chemical production has fallen by 2.4% in the first seven months of this year, compared with the same time period last year.
Pharmaceutical Executive October 1, 2012 Peter O'Donnell	Richard Bergstrom -- Europe's Medicine Man The new head of the European Federation of Pharmaceutical Industries and Associations faces a Promethean challenge: selling the merits of costly science and innovation in an era of bristling competition, fiscal crisis, and declining demographics.
<Older 3101-3110 Newer> Return to current articles.